Altium Capital Management LLC 13D/13G Filings for BriaCell Therapeutics Corp. (BCTX)

Altium Capital Management LLC 13D and 13G filings for BriaCell Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-11
8:39 pm
Purchase
2021-12-31 13G BriaCell Therapeutics Corp.
BCTX
Altium Capital Management LLC 60,000
4.700%
26,667increase
(+80.00%)
Filing
2021-03-08
4:16 pm
Purchase
2021-02-24 13G BriaCell Therapeutics Corp.
BCTX
Altium Capital Management LLC 33,333
8.900%
33,333increase
(New Position)
Filing